Enhanced glycolysis provides melanoma cells with abundant energy and metabolic intermediates, promoting the synthesis of proteins, nucleic acids, fatty acids, and other macromolecules needed for further growth and proliferation, while inhibiting the entire glycolysis process by targeting the BRAF or MAPK pathway may help hamper the growth and spread of melanoma (49). The gene discussed is BRAF; the disease is melanoma.